Use of nerve block for after surgery pain relief in breast surgery.

comparison of erector spinae block for postoperative analgesia in breast surgery- A randomised control trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012712

Enrollment

Registered

2018-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Breast tumour

Interventions

Intervention1: Erector spinae and bupivacaine: Erector spinae block will be given, 20ml 0.25% bupivacaine will be injected behind the erector spinae muscle and analgesia would be monitored for post

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for breast surgery (Modified Radical Masectomy, Simple mastectomy, Lumpectomy) ASA grade 1,2,3

Exclusion criteria

Exclusion criteria: ASA grade 4 Any allergy to local anaesthetics Patients refusal Infection at site of intervention

Design outcomes

Primary

Measure	Time frame
Postoperatively for 24 hours total opioid consumption.Timepoint: Every 4 hours for 24 hrs	—

Secondary

Measure	Time frame
Sensory block - loss of cold sensation of anterior and posterior roots of thoracic spinal nerve dermatomes Pain scores â?? numerical rating scores (NRS) will be used Timepoint: pain score will be assessed every 2 hrs for 24 hrs.	—

Countries

India

Contacts

Public Contactswati

Institute of medical sciences, patna

deepakswat@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 22, 2026